Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.33B | 5.34B | 4.81B | 4.57B | 4.38B | 3.08B |
Gross Profit | 2.20B | 2.31B | 2.07B | 2.01B | 2.23B | 1.55B |
EBITDA | 413.35M | 381.94M | 492.07M | 254.95M | 804.53M | 521.75M |
Net Income | 61.36M | 67.48M | 244.52M | 62.79M | 448.08M | 293.36M |
Balance Sheet | ||||||
Total Assets | 4.29B | 8.32B | 4.68B | 3.80B | 3.77B | 3.14B |
Cash, Cash Equivalents and Short-Term Investments | 3.18B | 3.74B | 3.45B | 2.37B | 2.18B | 2.00B |
Total Debt | 224.00M | 2.60B | 300.00M | 0.00 | 0.00 | 0.00 |
Total Liabilities | 849.00M | 4.25B | 1.11B | 614.63M | 747.46M | 605.71M |
Stockholders Equity | 3.39B | 3.39B | 3.53B | 3.16B | 2.98B | 2.51B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 102.65M | 275.36M | -758.00K | 337.81M | 353.62M |
Operating Cash Flow | 0.00 | 132.98M | 345.30M | 113.19M | 466.46M | 422.79M |
Investing Cash Flow | 0.00 | -1.68B | 236.38M | -191.93M | -283.61M | -349.17M |
Financing Cash Flow | 0.00 | 1.91B | 403.47M | 131.49M | -17.00K | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥2.97B | 11.88 | 2.52% | 5.84% | 7.76% | ||
70 Outperform | ¥2.48B | 18.51 | 2.29% | 18.75% | ― | ||
69 Neutral | ¥2.83B | 9.89 | 3.24% | 19.29% | 19.76% | ||
66 Neutral | ¥3.02B | 42.65 | 3.70% | 13.99% | -157.48% | ||
62 Neutral | £500.86M | 27.11 | 0.85% | 2.82% | 3.88% | -21.07% | |
55 Neutral | ¥2.79B | ― | ― | -4.53% | -237.38% | ||
47 Neutral | ¥4.19B | ― | ― | 2.84% | 40.04% |